Thermo Fisher Scientific Inc
TMO570.330USD
-5.580-0.97%
Cierre 12/16, 16:00（ET）Cotizaciones retrasadas 15 min
214.28BCap. mercado
32.91P/E TTM
Más Datos de Thermo Fisher Scientific Inc Compañía
Thermo Fisher Scientific Inc. is engaged in accelerating life sciences research, solving complex analytical challenges, increasing laboratory productivity, and improving patient health through diagnostics and the development and manufacture of life-changing therapies. Through its Life Sciences Solutions segment, it provides a portfolio of reagents, instruments and consumables used in biological and medical research, the discovery and production of new drugs and vaccines as well as diagnosis of infection and disease. Through its Analytical Instruments segment, it provides instruments and the supporting consumables, software and services that are used for a range of applications. Its Specialty Diagnostics segment offers a range of diagnostic test kits, reagents, culture media, instruments and associated products. Its Laboratory Products and Biopharma Services segment offers virtually everything needed for the laboratory. It also provides purification and filtration technologies.
Información de Thermo Fisher Scientific Inc
Símbolo de cotizaciónTMO
Nombre de la empresaThermo Fisher Scientific Inc
Fecha de salida a bolsaAug 27, 1980
Director ejecutivoCasper (Marc N)
Número de empleados125000
Tipo de seguridadOrdinary Share
Fin del año fiscalAug 27
Dirección168 Third Avenue
CiudadWALTHAM
Bolsa de valoresNASDAQ OMX NASDAQ Basic NYSE
PaísUnited States of America
Código postal02451
Teléfono17816221000
Sitio Webhttps://corporate.thermofisher.com/us/en/index.html
Símbolo de cotizaciónTMO
Fecha de salida a bolsaAug 27, 1980
Director ejecutivoCasper (Marc N)
Ejecutivos de Thermo Fisher Scientific Inc
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. Marc N. Casper
Mr. Marc N. Casper
Chairman of the Board, President, Chief Executive Officer
Chairman of the Board, President, Chief Executive Officer
112.55K
--
Mr. Michel Lagarde
Mr. Michel Lagarde
Chief Operating Officer, Executive Vice President
Chief Operating Officer, Executive Vice President
73.38K
+475.77%
Mr. Scott M. Sperling
Mr. Scott M. Sperling
Lead Independent Director
Lead Independent Director
73.03K
+0.78%
Mr. Stephen Williamson
Mr. Stephen Williamson
Chief Financial Officer, Senior Vice President
Chief Financial Officer, Senior Vice President
37.08K
-1.15%
Mr. Michael D. Shafer
Mr. Michael D. Shafer
Executive Vice President
Executive Vice President
18.98K
--
Mr. Nelson J. Chai
Mr. Nelson J. Chai
Independent Director
Independent Director
14.48K
+4.06%
Mr. Gianluca Pettiti
Mr. Gianluca Pettiti
Executive Vice President
Executive Vice President
11.48K
--
Ms. Lisa P. Britt
Ms. Lisa P. Britt
Chief Human Resources Officer, Senior Vice President
Chief Human Resources Officer, Senior Vice President
10.66K
-20.84%
Mr. Michael A. Boxer
Mr. Michael A. Boxer
Senior Vice President, General Counsel
Senior Vice President, General Counsel
8.87K
-29.85%
Dr. Tyler Jacks
Dr. Tyler Jacks
Director
Director
8.62K
+7.01%
Ver más
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. Marc N. Casper
Mr. Marc N. Casper
Chairman of the Board, President, Chief Executive Officer
Chairman of the Board, President, Chief Executive Officer
112.55K
--
Mr. Michel Lagarde
Mr. Michel Lagarde
Chief Operating Officer, Executive Vice President
Chief Operating Officer, Executive Vice President
73.38K
+475.77%
Mr. Scott M. Sperling
Mr. Scott M. Sperling
Lead Independent Director
Lead Independent Director
73.03K
+0.78%
Mr. Stephen Williamson
Mr. Stephen Williamson
Chief Financial Officer, Senior Vice President
Chief Financial Officer, Senior Vice President
37.08K
-1.15%
Mr. Michael D. Shafer
Mr. Michael D. Shafer
Executive Vice President
Executive Vice President
18.98K
--
Mr. Nelson J. Chai
Mr. Nelson J. Chai
Independent Director
Independent Director
14.48K
+4.06%
Desglose de ingresos
Divisa: USDActualizado: lun., 6 de oct
Divisa: USDActualizado: lun., 6 de oct
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2021
FY2020
FY2019
Por negocioUSD
Nombre
Ganancia
Proporción
Consumables
4.61B
42.43%
Service
4.61B
42.42%
Instruments
1.64B
15.15%
Por regiónUSD
Nombre
Ganancia
Proporción
North America
5.72B
52.71%
Europe
2.83B
26.07%
Asia Pacific
1.92B
17.69%
Other Regions
383.00M
3.53%
Por negocio
Por región
Por negocioUSD
Nombre
Ganancia
Proporción
Consumables
4.61B
42.43%
Service
4.61B
42.42%
Instruments
1.64B
15.15%
Estadísticas de accionistas
Actualizado: dom., 16 de nov
Actualizado: dom., 16 de nov
Accionistas
Tipos de accionistas
Accionistas
Accionistas
Proporción
The Vanguard Group, Inc.
8.96%
BlackRock Institutional Trust Company, N.A.
4.55%
State Street Investment Management (US)
4.36%
Capital World Investors
2.74%
Geode Capital Management, L.L.C.
2.17%
Otro
77.22%
Accionistas
Accionistas
Proporción
The Vanguard Group, Inc.
8.96%
BlackRock Institutional Trust Company, N.A.
4.55%
State Street Investment Management (US)
4.36%
Capital World Investors
2.74%
Geode Capital Management, L.L.C.
2.17%
Otro
77.22%
Tipos de accionistas
Accionistas
Proporción
Investment Advisor
50.57%
Investment Advisor/Hedge Fund
30.17%
Pension Fund
2.80%
Bank and Trust
2.73%
Research Firm
2.62%
Hedge Fund
1.91%
Sovereign Wealth Fund
1.86%
Family Office
0.20%
Family Office
0.20%
Otro
6.92%
Participación institucional
Actualizado: mié., 1 de oct
Actualizado: mié., 1 de oct
Periodo del informe
Número de instituciones
Acciones mantenidas
Proporción
Cambio
2025Q3
4341
344.96M
91.81%
-9.54M
2025Q2
4335
351.93M
93.19%
-4.42M
2025Q1
4395
350.27M
92.78%
-5.82M
2024Q4
4330
349.72M
92.67%
-4.90M
2024Q3
4195
348.49M
91.10%
-6.75M
2024Q2
4169
349.06M
91.37%
-3.26M
2024Q1
4150
346.74M
90.80%
-11.10M
2023Q4
4145
353.49M
91.48%
-3.65M
2023Q3
4035
353.30M
91.43%
-5.83M
2023Q2
4030
357.37M
92.63%
+1.15M
Ver más
Actividad de los accionistas
Nombre
Acciones mantenidas
Proporción
Cambio
Cambio %
Fecha
The Vanguard Group, Inc.
33.62M
8.9%
+304.63K
+0.91%
Jun 30, 2025
BlackRock Institutional Trust Company, N.A.
16.94M
4.49%
-335.33K
-1.94%
Jun 30, 2025
State Street Investment Management (US)
16.48M
4.36%
-58.52K
-0.35%
Jun 30, 2025
Capital World Investors
9.58M
2.54%
-1.48M
-13.41%
Jun 30, 2025
Geode Capital Management, L.L.C.
8.11M
2.15%
-12.40K
-0.15%
Jun 30, 2025
Fidelity Management & Research Company LLC
3.22M
0.85%
-727.96K
-18.43%
Jun 30, 2025
T. Rowe Price Associates, Inc.
5.00M
1.32%
-3.74M
-42.82%
Jun 30, 2025
Morgan Stanley Smith Barney LLC
5.61M
1.49%
+1.13M
+25.29%
Jun 30, 2025
Norges Bank Investment Management (NBIM)
5.59M
1.48%
-469.24K
-7.75%
Jun 30, 2025
Putnam Investment Management, L.L.C.
3.35M
0.89%
+55.55K
+1.69%
Jun 30, 2025
Ver más
ETFs relacionados
Actualizado: sáb., 6 de dic
Actualizado: sáb., 6 de dic
Nombre
Proporción
VanEck Morningstar Wide Moat Value ETF
5.72%
Goldman Sachs Future Health Care Equity ETF
5.09%
Honeytree US Equity ETF
4.9%
Parnassus Value Select ETF
4.52%
Health Care Select Sector SPDR Fund
4.39%
Proshares Ultra Health Care
4.24%
iShares U.S. Healthcare ETF
4.2%
AdvisorShares Focused Equity ETF
4.01%
GMO US Quality ETF
4%
Brookstone Value Stock ETF
3.97%
Ver más
VanEck Morningstar Wide Moat Value ETF
Proporción5.72%
Goldman Sachs Future Health Care Equity ETF
Proporción5.09%
Honeytree US Equity ETF
Proporción4.9%
Parnassus Value Select ETF
Proporción4.52%
Health Care Select Sector SPDR Fund
Proporción4.39%
Proshares Ultra Health Care
Proporción4.24%
iShares U.S. Healthcare ETF
Proporción4.2%
AdvisorShares Focused Equity ETF
Proporción4.01%
GMO US Quality ETF
Proporción4%
Brookstone Value Stock ETF
Proporción3.97%
Dividendos
Un total de
2.29B
USD se ha distribuido en dividendos durante los últimos 5 años.
Fecha
Dividendos
Fecha de registro
Fecha de pago
Fecha ex-dividendo
Jul 10, 2025
TMO.NB Final Cash Dividend of gross USD 0.43 paid on Oct 15, 2025 going ex on Sep 15, 2025
Sep 15, 2025
Oct 15, 2025
Sep 15, 2025
May 21, 2025
TMO.NB Interim Cash Dividend of gross USD 0.43 paid on Jul 15, 2025 going ex on Jun 13, 2025
Jun 13, 2025
Jul 15, 2025
Jun 13, 2025
Feb 19, 2025
TMO.NB Interim Cash Dividend of gross USD 0.43 paid on Apr 15, 2025 going ex on Mar 14, 2025
Mar 14, 2025
Apr 15, 2025
Mar 14, 2025
Nov 07, 2024
TMO.NB Interim Cash Dividend of gross USD 0.39 paid on Jan 15, 2025 going ex on Dec 13, 2024
Dec 13, 2024
Jan 15, 2025
Dec 13, 2024
Jul 11, 2024
TMO.NB Final Cash Dividend of gross USD 0.39 paid on Oct 15, 2024 going ex on Sep 13, 2024
Sep 13, 2024
Oct 15, 2024
Sep 13, 2024
May 22, 2024
TMO.NB Interim Cash Dividend of gross USD 0.39 paid on Jul 15, 2024 going ex on Jun 14, 2024
Jun 14, 2024
Jul 15, 2024
Jun 14, 2024
Feb 21, 2024
TMO.NB Interim Cash Dividend of gross USD 0.39 paid on Apr 15, 2024 going ex on Mar 14, 2024
Mar 15, 2024
Apr 15, 2024
Mar 14, 2024
Nov 09, 2023
TMO.NB Interim Cash Dividend of gross USD 0.35 paid on Jan 16, 2024 going ex on Dec 14, 2023
Dec 15, 2023
Jan 16, 2024
Dec 14, 2023
Jul 13, 2023
TMO.NB Final Cash Dividend of gross USD 0.35 paid on Oct 13, 2023 going ex on Sep 14, 2023
Sep 15, 2023
Oct 13, 2023
Sep 14, 2023
May 24, 2023
TMO.NB Interim Cash Dividend of gross USD 0.35 paid on Jul 14, 2023 going ex on Jun 14, 2023
Jun 15, 2023
Jul 14, 2023
Jun 14, 2023
Ver más
División de acciones
Fecha
Tipo
Relación
Sin datos
Fecha
Tipo
Relación
Sin datos
Preguntas frecuentes
¿Quiénes son los cinco principales accionistas de Thermo Fisher Scientific Inc?
Los cinco principales accionistas de Thermo Fisher Scientific Inc son:
The Vanguard Group, Inc. posee 33.62M acciones, lo que representa el 8.90% del total de acciones.
BlackRock Institutional Trust Company, N.A. posee 16.94M acciones, lo que representa el 4.49% del total de acciones.
State Street Investment Management (US) posee 16.48M acciones, lo que representa el 4.36% del total de acciones.
Capital World Investors posee 9.58M acciones, lo que representa el 2.54% del total de acciones.
Geode Capital Management, L.L.C. posee 8.11M acciones, lo que representa el 2.15% del total de acciones.
The Vanguard Group, Inc. posee 33.62M acciones, lo que representa el 8.90% del total de acciones.
BlackRock Institutional Trust Company, N.A. posee 16.94M acciones, lo que representa el 4.49% del total de acciones.
State Street Investment Management (US) posee 16.48M acciones, lo que representa el 4.36% del total de acciones.
Capital World Investors posee 9.58M acciones, lo que representa el 2.54% del total de acciones.
Geode Capital Management, L.L.C. posee 8.11M acciones, lo que representa el 2.15% del total de acciones.
¿Cuáles son los tres principales tipos de accionista de Thermo Fisher Scientific Inc?
Los tres principales tipos de accionista de Thermo Fisher Scientific Inc son:
The Vanguard Group, Inc.
BlackRock Institutional Trust Company, N.A.
State Street Investment Management (US)
The Vanguard Group, Inc.
BlackRock Institutional Trust Company, N.A.
State Street Investment Management (US)
¿Cuántas instituciones poseen acciones de Thermo Fisher Scientific Inc (TMO)?
A fecha de 2025Q3, 4341 instituciones poseen acciones de Thermo Fisher Scientific Inc, con un valor de mercado combinado de aproximadamente 344.96M, lo que representa el 91.81% del total de acciones. En comparación con el 2025Q2, el accionariado institucional ha aumentado en -1.39%.
¿Cuál es la mayor fuente de ganancias de Thermo Fisher Scientific Inc?
El FY2025Q2, el segmento empresarial Consumables generó la ganancia más alta para Thermo Fisher Scientific Inc, ascendiendo a 4.61B y representando el 42.43% de la ganancia total.
